Bayer MaterialScience has stated that it is bringing ‘its work on carbon nanotubes (CNTs) to a close’, stating that it wishes to ‘focus its development activities more intently on topics that are closely linked to its core business’. Although the material is considered to have great potential, Bayer’s management does not believe “[…] comprehensive commercialization [is] […] likely in the foreseeable future”.
Providing more detail, it has been explained that ‘it has been found […] that the potential areas of application that once seemed promising from a technical standpoint are currently very fragmented or have few overlaps with the company’s core products and their application spectrum’.
As Bayer has developed an in-depth understanding of CNTs, it believes its ‘[…] know-how provides an important basis for a possible later use of CNTs, for example in the optimization of lithium-ion batteries’. Nevertheless it is currently unclear what will happen to both its research and the Innovation Alliance Carbon Nanotubes (Inno.CNT) it helped found with the German government.